Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
2012 ◽
Vol 14
(12)
◽
pp. 1061-1072
◽
2020 ◽
Vol 24
(2)
◽
pp. 143